Inserm at a Glance

Founded in 1964, Inserm is a public scientific and technological institute which operates under the joint authority of the French Ministries of Health and Research. The institute is dedicated to biomedical research and human health, and is involved in the entire range of activities from the laboratory to the patient’s bedside. It also partners with the most prestigious research institutions in the world that are committed to scientific challenges and progress in these fields.

Chairman and Chief Executive Officer 
Gilles Bloch
Executive Vice President, Strategy 
Thomas Lombès
Executive Vice President, Administration 
Damien Rousset

12 Regional Delegations
9 Theme-Based Institutes

More than 13,200 scientific publications in 2020 i.e. :
15% of French production, all research fields combined
38% of publications in the biological and medical fields

More than 2,000 active patent families 
in 2020. Inserm is the :
1st European patent applicant in the pharmaceutical sector
2nd in the biotechnology category
8th French patent applicant, all organizations and sectors combined

263 research units
40 service units
34 clinical investigation centers

1st academic organization in biomedical research in Europe
2 international mixed units
30 foreign laboratories integrated in the Inserm International research projects program
10 foreign laboratories integrated into a CNRS-Inserm international research network

2 Nobel Prizes 
Jean Dausset (1980) Françoise Barré-Sinoussi (2008)
3 Lasker Prizes
Etienne-Emile Baulieu (1989) Pierre Chambon (2004) Alim-Louis Benabid (2014)

5,047 civil servants, including 2,144 researchers and 2,903 engineers and technicians
3,257 contract staff and temporary workers
5,499 university-hospitals and universities staff personnel

Initial budget 2021 967.36 M€
External resources 32.6%
State funding  67.4%

Learn more about Inserm